Dose Escalation Study of Simultaneous Boost Intensity-Modulated Radiotherapy for Locally Advanced Cervical Cancer
Status:
Completed
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
This will be the first study to assess the clinical feasibility of dose escalation with
simultaneous integrated boost intensity-modulated radiotherapy for patients with locally
advanced cervical cancer. Following screening to confirm eligibility patients will commence a
six week treatment period. After this, patients will be followed up by visits to clinic every
3 months for a period of 24 months (2 years). End of study is defined as 24 months after
treatment. Patients will be followed up for a minimum of 5 years (as per local policy) after
treatment.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Barts & The London NHS Trust Queen Mary University of London
Collaborators:
Barts & The London NHS Trust Barts Cancer Institute